Nalls Sherbakoff Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.6K Hold
72
﹤0.01% 294
2026
Q1
$6.14K Hold
72
﹤0.01% 327
2025
Q4
$5.69K Hold
72
﹤0.01% 359
2025
Q3
$5.76K Hold
72
﹤0.01% 350
2025
Q2
$6.54K Hold
72
﹤0.01% 347
2025
Q1
$6.75K Buy
+72
New +$6.45K 0.01% 319
2023
Q4
$5.74K Hold
72
0.01% 294
2023
Q3
$5.12K Hold
72
0.01% 295
2023
Q2
$5.36K Hold
72
0.01% 297
2023
Q1
$5.42K Buy
+72
New +$5.35K 0.01% 296
2018
Q4
$4K Buy
+72
New +$4.5K 0.01% 316

Other funds holding CL

Nalls Sherbakoff Group's CL Position: Q2 2026 in Review

Nalls Sherbakoff Group held its Colgate-Palmolive (CL) position steady in Q2 2026 at 72 shares worth $6.6K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Nalls Sherbakoff Group first reported a position in CL in Q4 2018 and has held it in 11 quarters since. The position peaked at $6.75K in Q1 2025. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Nalls Sherbakoff Group held 72 shares of Colgate-Palmolive worth $6.6K as of Q2 2026.
  • Nalls Sherbakoff Group left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up ﹤0.01% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #294 holding.
  • Nalls Sherbakoff Group first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 11 quarters since.
  • Nalls Sherbakoff Group's Colgate-Palmolive position peaked at $6.75K in Q1 2025.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.